BioVaxys Technology (TSE:BIOV) has released an update.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts and uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
BioVaxys Technology Corp., a clinical-stage biotech firm, is set to present at the Life Sciences Investor Forum on September 19, 2024, inviting investors and analysts to join the live event online. The company, which specializes in developing therapies for cancers and infectious diseases, will offer opportunities for real-time interaction and scheduled one-on-one meetings with investors.
For further insights into TSE:BIOV stock, check out TipRanks’ Stock Analysis page.
